Filing Flows

Filing Flows › Zimmer Biomet Holdings (ZBH) › Next earnings date

Zimmer Biomet Holdings (ZBH) earnings: beat the estimate

Zimmer Biomet Holdings (ZBH) reported on Nov 4, 2026 and beat the EPS estimate: $1.90 against $1.88 (+1.0%). Revenue was $2.1B for Q3 2026, +3% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+1.0% vs estimate
Beat rate100%

The last report

Zimmer Biomet Holdings reported revenue of $2.1B for the third quarter 2026 (+3% Y/Y), net earnings $193M: Knees $768M, SET $578M, Hips $536M, Technology and Data Bone Cement and Surgical $181M. How it makes money → · Every quarter →

Zimmer Biomet Holdings: EPS against the estimate, last 5 reportsZimmer Biomet Holdings: EPS against the estimate, last 5 reportsEstimateReported$1.87$1.90Nov 25$2.40$2.42Feb 26$1.86$2.09Apr 26$2.01$2.07Aug 26$1.88$1.90Nov 26
Latest (Nov 26): Estimate $1.88, Reported $1.90.
ZBH: the stock's move on each reportZBH: the stock's move on each reportAug 5, 2026+1.4%Apr 28, 2026-13.5%Feb 10, 2026+6.6%Nov 5, 2025-14.2%

Zimmer Biomet Holdings' latest quarter

Zimmer Biomet Holdings, Q3 2026: revenue $2.1B (+3% year over year), operating margin 14.9%, net earnings $193M, operating cash flow $560M. The chart follows the revenue to costs, profit and cash.

Questions

Did Zimmer Biomet Holdings beat earnings?

Zimmer Biomet Holdings (ZBH) reported on Nov 4, 2026 and beat the EPS estimate: $1.90 against $1.88 (+1.0%).

When does ZBH report earnings?

The next date is not set yet.

Does Zimmer Biomet Holdings usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.